Medicine and Dentistry
Glomerulopathy
100%
Disease
72%
Chronic Kidney Disease
58%
Atypical Hemolytic Uremic Syndrome
52%
Biopsy
49%
Hemodialysis
47%
Nephropathy
44%
End Stage Renal Disease
44%
Nephrology
40%
Nephrologist
36%
Primary Health Care
36%
COVID-19
36%
Focal Segmental Glomerulosclerosis
35%
Glomerular Filtration Rate
34%
Biological Marker
33%
Disease Activity
31%
Kidney Function
30%
Acute Kidney Injury
29%
Mixed Infection
25%
Microangiopathy
25%
Quality of Life
24%
Amyloid
24%
Human Immunodeficiency Virus
24%
Diagnosis
24%
Minimal Change Disease
23%
Thrombotic Thrombocytopenic Purpura
22%
Membranoproliferative Glomerulonephritis
16%
Clinician
16%
Amyloidosis
16%
Disease Course
15%
Hepatitis C
15%
Thrombocytopenia
15%
Complement Inhibition
15%
Complement Alternative Pathway
15%
Raman Spectrometry
14%
Onset Age
14%
Observational Study
14%
Ex Vivo
14%
Renal Biopsy
13%
Proteinuria
13%
Platelet
13%
Complement Activation
13%
Complement Component C5b
13%
Emergency Care
13%
Attitude
13%
IgA Vasculitis
13%
Immunoglobulin A Nephropathy
12%
Membranous Glomerulonephritis
12%
Cell Surface
12%
Rituximab
12%
Keyphrases
Chronic Kidney Disease
60%
Glomerular Disease
44%
COVID-19
33%
Glomerulonephropathy
33%
Nephrologists
31%
Focal Segmental Glomerulosclerosis
31%
Continuous Renal Replacement Therapy
28%
Atypical Hemolytic Uremic Syndrome (aHUS)
27%
Biopsy-proven
25%
Estimated Glomerular Filtration Rate
25%
Dialysis
24%
Thrombotic Microangiopathy
24%
Primary Care Physicians
24%
Disease Activity
24%
Alternative Complement Pathway
23%
Nephrology
23%
Kidney Disease
22%
Remission
22%
IgA Nephropathy (IgAN)
19%
Minimal Change Disease
19%
Confidence Interval
18%
Proteinuria
17%
Odds Ratio
16%
Blood Pressure
16%
End-stage Renal Disease
16%
Hemodialysis
16%
United States
16%
High Risk
15%
Patient Management
15%
Complement Inhibition
15%
Kidney Function Decline
14%
Primary Glomerulonephritis
14%
Complement Pathway
14%
Primary Care
14%
Protein-to-creatinine Ratio
13%
Acute Kidney Injury
13%
Survivors
13%
Mixed-methods Study
13%
Thrombotic Thrombocytopenic Purpura
13%
Physician Perspective
13%
High Prevalence
13%
Intensive Care Unit
12%
Elevated Liver Enzymes
12%
Danicopan
12%
Urinary Tract Infection
12%
IgA Vasculitis (IgAV)
12%
Positive Potential
12%
Uncomplicated UTI
12%
Nephrology Referral
12%
Drug-induced Hypertension
12%
